Soc. Generale Call 125 DVA 20.09..../ DE000SQ3J6L4 /
2024-06-21 9:46:59 PM | Chg.+0.180 | Bid9:59:53 PM | Ask9:59:53 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.140EUR | +9.18% | 2.040 Bid Size: 2,000 |
2.090 Ask Size: 2,000 |
DaVita Inc | 125.00 USD | 2024-09-20 | Call |
Newsfile Corp
06-18
Healing Realty Trust Closes First Tranche of Series A to Expand Clinic-Focused Portfolio for a New G...
GlobeNewswire
04-26
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
2023-11-17
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
2023-08-15
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
2022-03-21
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
2022-03-07
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
2022-02-10
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
2021-10-07
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
2021-10-01
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
GlobeNewswire
2021-09-09
ACTION BEHAVIOR CENTERS HIRES NEW GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER